Global /United States /Healthcare /Medical Devices /STXS
chevron_leftBack
Stereotaxis, Inc. logo

Stereotaxis, Inc.

STXS
NYSEAMERICAN: STXS Delayed
1.82USD -2.2%
As of 14 June 2026, Stereotaxis, Inc. has a market cap of $177.41M USD, ranking #21825 globally and #3532 in the United States. It ranks #1959 in the Healthcare sector, and #404 in the Medical Devices industry.
Global Rank
21825
Country Rank
3532
Sector Rank
1959
Industry Rank
404
Key Stats
Market Cap
$177.41MUSD
Enterprise Value
$165.53MUSD
Revenue (TTM)
$32.38MUSD
EBITDA (TTM)
-$18.39MUSD
Net Income (TTM)
-$22.91MUSD
EBITDA Margin
-57%
Profit Margin
-67%
PS Ratio
5.4
PB Ratio
13.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
David Fischel open_in_new
Employees
131
Founded
1990
IPO
12 Aug 2004
Website
stereotaxis.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.2% -7.8% -2.7% -29% -40% -11%

News

Loading...

STXS Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE American
MIC: XASE
PRIMARY
STXS
Stereotaxis Inc
ISIN: US85916J4094
Shares Out.:
97.737M1 Shares Float: 82.227M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
1.82 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Stereotaxis, Inc.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
98K%
25.8
$160.73B
90K%
56.7
$159.07B
90K%
25.6
DHR
$126.55B
71K%
34.7
SYK
$120.69B
68K%
38.3
$84.93B
48K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
57K%
22.2
$97.46B
84.32B EUR
55K%
36.7
7741
$61.41B
9.83T JPY
35K%
40.0
$45.47B
39.34B EUR
26K%
18.7
ALC
$36.38B
28.99B CHF
20K%
37.9
$30.06B
203.66B CNY
17K%
26.0
chevron_leftBack